Figure 4From: Preclinical evaluation of dasatinib, a potent Src kinase inhibitor, in melanoma cell linesEffect of dasatinib on (A) invasion and (B) migration in HT144 and Sk-Mel-28 melanoma cell lines. Error bars represent the standard deviation of triplicate assays. '*' indicates p < 0.05.Back to article page